Literature DB >> 10773922

Childhood lymphoma.

K Windebank1.   

Abstract

Lymphoma accounts for some 10% of childhood malignancy. Hodgkins disease is slightly less common than Non Hodgkins lymphoma, of which lymphoblastic, Burkitts and large cell anaplastic are the common subtypes. Accurate subtyping and staging are critical to ensure correct therapy is initiated. With current therapeutic strategies, almost all cases of Hodgkins and in excess of 70% of Non Hodgkins lymphomas can be cured.

Entities:  

Mesh:

Year:  1998        PMID: 10773922     DOI: 10.1007/BF02731040

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  19 in total

1.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

Review 2.  The treatment of Hodgkin's disease.

Authors:  H S Kaplan; S A Rosenberg
Journal:  Med Clin North Am       Date:  1966-11       Impact factor: 5.456

3.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

Review 4.  Hodgkin's disease.

Authors:  K P Windebank; G S Gilchrist
Journal:  Pediatr Ann       Date:  1988-03       Impact factor: 1.132

5.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

6.  Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.

Authors:  A G Shankar; S Ashley; M Radford; A Barrett; D Wright; C R Pinkerton
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

7.  Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.

Authors:  S B Murphy
Journal:  Semin Oncol       Date:  1980-09       Impact factor: 4.929

8.  A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.

Authors:  T J McElwain; J Toy; E Smith; M J Peckham; D E Austin
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

9.  Life-threatening airway obstruction as a complication to the management of mediastinal masses in children.

Authors:  R G Azizkhan; D L Dudgeon; J R Buck; P M Colombani; M Yaster; D Nichols; C Civin; S S Kramer; J A Haller
Journal:  J Pediatr Surg       Date:  1985-12       Impact factor: 2.545

10.  Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.

Authors:  O B Eden; I Hann; J Imeson; S Cotterill; M Gerrard; C R Pinkerton
Journal:  Br J Haematol       Date:  1992-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.